Lipoproteins and lipoprotein metabolism in periodontal disease

Clinical Lipidology

Volumn 5, Issue 3, 2010, Pages 397-411

  Griffiths, Rachel ^a   Barbour, Suzanne ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

high density lipoprotein; low density lipoprotein; oxidized LDL; periodontal disease; periodontal therapy; periodontitis; porphyromonas gingivalis; triglyceride

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DYSLIPIDEMIA; HUMAN; INCIDENCE; LIPOPROTEIN METABOLISM; PERIODONTAL DISEASE; PRIORITY JOURNAL; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

PORPHYROMONAS GINGIVALIS;

EID: 77953854161     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/clp.10.27     Document Type: Review

References (199)

1. Abou-Raya S, Naeem A, Kheir HA-E, El Beltagy S: Coronary artery disease and periodontal disease: is there a link? Angiology 53(2), 141-148 (2002).
2. Paquette DW, Brodala N, Nichols TC: Cardiovascular disease, inflammation, and periodontal infection. Periodontol. 44, 113-126 (2007).
3. Nieto FJ: Infective agents and cardiovascular disease. Semin.Vasc. Med. 2(4), 401-415 (2002).
4. Gibson FC III, Yumoto H, Takahashi Y, Chou HH, Genco CA: Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. J. Dent. Res. 85(2), 106-121 (2006).
5. Ridker PM, Silvertown JD: Inflammation, C-reactive protein, and atherothrombosis. J. Periodontol. 79(Suppl. 8), 1544-1551 (2008).
6. Galkina E, Ley K: Immune and inflammatory mechanisms of atherosclerosis. Ann. Rev. Immunol. 27(1), 165-197 (2009).
7. Chun YH, Chun KR, Olguin D, Wang HL: Biological foundation for periodontitis as a potential risk factor for atherosclerosis. J. Periodontal. Res. 40(1), 87-95 (2005).
8. Karnoutsos K, Papastergiou P, Stefanidis S, Vakaloudi A: Periodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anti-cardiolipin antibodies. Hippokratia 12(3), 144-149 (2008).
9. Niedzielska I, Janic T, Cierpka S, Swietochowska E: The effect of chronic periodontitis on the development of atherosclerosis: review of the literature. Med. Sci. Monit. 14(7), RA103-RA106 (2008).
10. Meyer DH, Fives-Taylor PM: Oral pathogens: from dental plaque to cardiac disease. Curr. Opin. Microbiol. 1(1), 88-95 (1998).
11. Mustapha IZ, Debrey S, Oladubu M, Ugarte R: Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J. Periodontol. 78(12), 2289-2302 (2007).
12. Paraskevas S, Huizinga JD, Loos BG: A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J. Clin. Periodontol. 35(4), 277-290 (2008).
13. Offenbacher S, Beck JD: A perspective on the potential cardioprotective benefits of periodontal therapy. Am. Heart J. 149(6), 950-954 (2005).
14. Elter JR, Champagne CME, Offenbacher S, Beck JD: Relationship of periodontal disease and tooth loss to prevalence of coronary heart disease. J. Periodontol. 75(6), 782-790 (2004).
15. Dietrich T, Jimenez M, Krall Kaye EA, Vokonas PS, Garcia RI: Age-dependent associations between chronic periodontitis/edentulism and risk of coronary heart disease. Circulation 117(13), 1668-1674 (2008).
16. Andriankaja OM, Genco RJ, Dorn J et al.: The use of different measurements and definitions of periodontal disease in the study of the association between periodontal disease and risk of myocardial infarction. J. Periodontol. 77(6), 1067-1073 (2006).
17. Holmlund A, Holm G, Lind L: Severity of periodontal disease and number of remaining teeth are related to the prevalence of myocardial infarction and hypertension in a study based on 4,254 subjects. J. Periodontol. 77(7), 1173-1178 (2006).
18. Emingil G, Buduneli E, Aliyev A, Akilli A, Atilla G: Association between periodontal disease and acute myocardial infarction. J. Periodontol. 71(12), 1882-1886 (2000).
19. Nakib SA, Pankow JS, Beck JD: Periodontitis and coronary artery calcification - the Atherosclerosis Risk in Communities (ARIC) Study. J. Periodontol. 75, 505-510 (2004).
20. Soder PO, Soder B, Nowak J, Jogestrand T: Early carotid atherosclerosis in subjects with periodontal diseases. Stroke 36(6), 1195-1200 (2005).
21. Leivadaros E, van der Velden U, Bizzarro S et al.: A pilot study into measurements of markers of atherosclerosis in periodontitis. J. Periodontol. 76(1), 121-128 (2005).
22. Soder B, Yakob M, Nowak J, Jogestrand T: Risk for the development of atherosclerosis in women with a high amount (corrected) of dental plaque and severe gingival inflammation. Int. J. Dent. Hyg. 5(3), 133-138 (2007).
23. Cairo F, Castellani S, Gori AM et al.: Severe periodontitis in young adults is associated with sub-clinical atherosclerosis. J. Clin. Periodontol. 35(6), 465-472 (2008).
24. Beck JD, Elter JR, Heiss G, Couper D, Mauriello SM, Offenbacher S: Relationship of periodontal disease to carotid artery intima-media wall thickness: the atherosclerosis risk in communities (ARIC) Study. Arterioscler. Thromb. Vasc. Biol. 21, 1816-1822 (2001).
25. Engebretson SP, Lamster IB, Elkind MSV et al.: Radiographic measures of chronic periodontitis and carotid artery plaque. Stroke 36(3), 561-566 (2005).
26. Desvarieux M, Demmer RT, Rundek T et al.: Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke 34(9), 2120-2125 (2003).
27. Desvarieux M, Schwahn C, Volzke H et al.: Gender differences in the relationship between periodontal disease, tooth loss, and atherosclerosis. Stroke 35(9), 2029-2035 (2004).
28. Lu B, Parker D, Eaton CB: Relationship of periodontal attachment loss to peripheral vascular disease: an analysis of NHANES 1999-2002 data. Atherosclerosis 200(1), 199-205 (2008).
29. Chen YW, Umeda M, Nagasawa T et al.: Periodontitis may increase the risk of peripheral arterial disease. Eur. J. Vasc. Endovasc. Surg. 35(2), 153-158 (2008).
30. Beck JD, Eke P, Lin D et al.: Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults. Atherosclerosis 183(2), 342-348 (2005).
31. Pussinen PJ, Alfthan G, Jousilahti P, Paju S, Tuomilehto J: Systemic exposure to Porphyromonas gingivalis predicts incident stroke. Atherosclerosis 193(1), 222-228 (2007).
32. Ebersole JL, Machen RL, Steffen MJ, Willmann DE: Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin. Exp. Immunol. 107(2), 347-352 (1997).
33. Salzberg TN, Overstreet BT, Rogers JD, Califano JV, Best AM, Schenkein HA: C-reactive protein levels in patients with aggressive periodontitis. J. Periodontol. 77(6), 933-939 (2006).
34. Linden GJ, McClean K, Young I, Evans A, Kee F: Persistently raised C-reactive protein levels are associated with advanced periodontal disease. J. Clin. Periodontol. 35(9), 741-747 (2008).
35. Papapanagiotou D, Nicu EA, Bizzarro S et al.: Periodontitis is associated with platelet activation. Atherosclerosis 202(2), 605-611 (2009).
36. Joshipura KJ, Wand HC, Merchant AT, Rimm EB: Periodontal disease and biomarkers related to cardiovascular disease. J. Dent. Res. 83(2), 151-155 (2004).
37. Schwahn C, Volzke H, Robinson DM et al.: Periodontal disease, but not edentulism, is independently associated with increased plasma fibrinogen levels. Results from a population-based study. Thromb. Haemost. 92(2), 244-252 (2004).
38. Sun XJ, Meng HX, Shi D et al.: Elevation of C-reactive protein and interleukin-6 in plasma of patients with aggressive periodontitis. J. Periodontal. Res. 44(3), 311-316 (2009).
39. Schenkein HA, Best AM, Brooks CN et al.: Anti-cardiolipin and increased serum adhesion molecule levels in patients with aggressive periodontitis. J. Periodontol. 78(3), 459-466 (2007).
40. Persson GR, Pettersson T, Ohlsson O, Renvert S: High-sensitivity serum C-reactive protein levels in subjects with or without myocardial infarction or periodontitis. J. Clin. Periodontol. 32(3), 219-224 (2005).
41. Slade GD, Ghezzi EM, Heiss G, Beck JD, Riche E, Offenbacher S: Relationship between periodontal disease and C-reactive protein among adults in the atherosclerosis risk in communities study. Arch. Intern. Med. 163(10), 1172-1179 (2003).
42. Amabile N, Susini G, Pettenati-Soubayroux I et al.: Severity of periodontal disease correlates to inflammatory systemic status and independently predicts the presence and angiographic extent of stable coronary artery disease. J. Intern. Med. 263(6), 644-652 (2008).
43. Saito T, Murakami M, Shimazaki Y, Oobayashi K, Matsumoto S, Koga T: Association between alveolar bone loss and elevated serum C-reactive protein in Japanese men. J. Periodontol. 74(12), 1741-1746 (2003).
44. Genctoy G, Ozbek M, Avcu N et al.: Gingival health status in renal transplant recipients: relationship between systemic inflammation and atherosclerosis. Int. J. Clin. Pract. 61(4), 577-582 (2007).
45. Haynes WG, Stanford C: Periodontal disease and atherosclerosis: from dental to arterial plaque. Arterioscler. Thromb. Vasc. Biol. 23(8), 1309-1311 (2003).
46. Savage A, Eaton KA, Moles DR, Needleman I: A systematic review of definitions of periodontitis and methods that have been used to identify this disease. J. Clin. Periodontol. 36(6), 458-467 (2009).
47. Armitage GC: Classifying periodontal diseases - a long-standing dilemma. Periodontol. 30, 9-23 (2002).
48. Armitage GC: Periodontal diagnoses and classification of periodontal diseases. Periodontol. 34, 9-21 (2004).
49. D'Aiuto F, Sabbah W, Netuveli G et al.: Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J. Clin. Endocrinol. Metab. 93(10), 3989-3994 (2008).
50. Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, Battino M: Metabolic syndrome and periodontitis: is oxidative stress a common link? J. Dent. Res. 88(6), 503-518 (2009).
51. Shimazaki Y, Saito T, Yonemoto K, Kiyohara Y, Iida M, Yamashita Y: Relationship of metabolic syndrome to periodontal disease in Japanese women: the Hisayama Study. J. Dent. Res. 86(3), 271-275 (2007).
52. Nishimura F, Soga Y, Iwamoto Y, Kudo C, Murayama Y: Periodontal disease as part of the insulin resistance syndrome in diabetic patients. J. Int. Acad. Periodontol. 7(1), 16-20 (2005).
53. Xiong X, Buekens P, Fraser WD, Beck J, Offenbacher S: Periodontal disease and adverse pregnancy outcomes: a systematic review. BJOG 113(2), 135-143 (2006).
54. Offenbacher S: Maternal periodontal infections, prematurity, and growth restriction. Clin. Obstet. Gynecol. 47(4), 808-821 (2004).
55. Valtonen VV: Role of infections in atherosclerosis. Am. Heart J. 138(5 Pt 2), S431-S433 (1999).
56. Valtonen VV: Infection as a risk factor for infarction and atherosclerosis. Ann. Med. 23(5), 539-543 (1991).
57. Abou-Raya S, Abou-Raya A, Naim A, Abuelkheir H: Rheumatoid arthritis, periodontal disease and coronary artery disease. Clin. Rheumatol. 27(4), 421-427 (2008).
58. Dorn BR, Dunn WA Jr, Progulske-Fox A: Invasion of human coronary artery cells by periodontal pathogens. Infect. Immun. 67(11), 5792-5798 (1999).
59. Roth GA, Moser B, Huang SJ et al.: Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. J. Thromb. Haemost. 4(10), 2256-2261 (2006).
60. Yumoto H, Yamada M, Shinohara C et al.: Soluble products from Eikenella corrodens induce cell proliferation and expression of interleukin-8 and adhesion molecules in endothelial cells via mitogen-activated protein kinase pathways. Oral Microbiol. Immunol. 22(1), 36-45 (2007).
61. Nakamura N, Yoshida M, Umeda M et al.: Extended exposure of lipopolysaccharide fraction from Porphyromonas gingivalis facilitates mononuclear cell adhesion to vascular endothelium via Toll-like receptor-2 dependent mechanism. Atherosclerosis 196(1), 59-67 (2008).
62. Nassar H, Chou HH, Khlgatian M, Gibson FC III, Dyke TEV, Genco CA: Role for Fimbriae and lysine-specific cysteine proteinase gingipain k in expression of interleukin-8 and monocyte chemoattractant protein in Porphyromonas gingivalis-infected endothelial cells. Infect. Immun. 70(1), 268-276 (2002).
63. Inaba H, Hokamura K, Nakano K et al.: Upregulation of S100 calcium-binding protein A9 is required for induction of smooth muscle cell proliferation by a periodontal pathogen. FEBS Lett. 583(1), 128-134 (2009).
64. Roth GA, Aumayr K, Giacona MB, Papapanou PN, Schmidt AM, Lalla E: Porphyromonas gingivalis infection and prothrombotic effects in human aortic smooth muscle cells. Thromb. Res. 123(5), 780-784 (2009).
65. Hajishengallis G, Sharma A, Russell MW, Genco RJ: Interactions of oral pathogens with Toll-like receptors: possible role in atherosclerosis. Ann. Periodontol. 7(1), 72-78 (2002).
66. Hasebe A, Yoshimura A, Into T et al.: Biological activities of bacteroides forsythus lipoproteins and their possible pathological roles in periodontal disease. Infect. Immun. 72(3), 1318-1325 (2004).
67. Harokopakis E, Albzreh MH, Martin MH, Hajishengallis G: TLR2 transmodulates monocyte adhesion and transmigration via Rac1- and PI3K-mediated inside-out signaling in response to Porphyromonas gingivalis fimbriae. J. Immunol. 176(12), 7645-7656 (2006).
68. Hajishengallis G, Sojar H, Genco RJ, DeNardin E: Intracellular signaling and cytokine induction upon interactions of Porphyromonas gingivalis fimbriae with pattern-recognition receptors. Immunol. Invest. 33(2), 157-172 (2004).
69. Naito M, Sakai E, Shi Y et al.: Porphyromonas gingivalis-induced platelet aggregation in plasma depends on Hgp44 adhesin but not Rgp proteinase. Mol. Microbiol. 59(1), 152-167 (2006).
70. Sharma A, Novak EK, Sojar HT, Swank RT, Kuramitsu HK, Genco RJ: Porphyromonas gingivalis platelet aggregation activity: outer membrane vesicles are potent activators of murine platelets. Oral Microbiol. Immunol. 15(6), 393-396 (2000).
71. Elter JR, Offenbacher S, Toole JF, Beck JD: Relationship of periodontal disease and edentulism to stroke/TIA. J. Dent. Res. 82(12), 998-1001 (2003).
72. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U: Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J. Periodontol. 71(10), 1528-1534 (2000).
73. Tabrizi F, Buhlin K, Gustafsson A, Klinge B: Oral health of monozygotic twins with and without coronary heart disease: a pilot study. J. Clin. Periodontol. 34(3), 220-225 (2007).
74. Briggs JE, McKeown PP, Crawford VLS et al.: Angiographically confirmed coronary heart disease and periodontal disease in middle-aged males. J. Periodontol. 77(1), 95-102 (2006).
75. Willershausen B, Kasaj A, Willershausen I et al.: Association between chronic dental infection and acute myocardial infarction. J. Endod. 35(5), 626-630 (2009).
76. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S: Periodontal disease and cardiovascular disease. J. Periodontol. 67(Suppl. 10), 1123-1137 (1996).
77. Schaefer AS, Richter GM, Groessner-Schreiber B et al.: Identification of a shared genetic susceptibility locus for coronary heart disease and periodontitis. PLoS Genet. 5(2), E1000378 (2009).
78. Scannapieco FA, Bush RB, Paju S: Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systemic review. Ann. Periodontol. 8, 38-53 (2003).
79. Persson GR, Persson RE: Cardiovascular disease and periodontitis: an update on the associations and risk. J. Clin. Periodontol. 35(Suppl. 8), 362-379 (2008).
80. Beck JD, Offenbacher S: The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review. Ann. Periodontol. 6(1), 9-15 (2001).
81. Jacobs DR Jr, Crow RS: Subclinical cardiovascular disease markers applicable to studies of oral health: multiethnic study of atherosclerosis. Ann. NY Acad. Sci. 1098, 269-287 (2007).
82. Deckelbaum RJ, Shipley GG, Small DM: Structure and interactions of lipids in human plasma low density lipoproteins. J. Biol. Chem. 252(2), 744-754 (1977).
83. Berneis KK, Krauss RM: Metabolic origins and clinical significance of LDL heterogeneity. J. Lipid. Res. 43(9), 1363-1379 (2002).
84. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J. Lipid. Res. 23(1), 97-104 (1982).
85. Verhoye E, Langlois MR: Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk? Clin. Chem. Lab. Med. 47(2), 128-137 (2009).
86. Davidson MH: Apolipoprotein measurements: is more widespread use clinically indicated? Clin. Cardiol. 32(9), 482-486 (2009).
87. Therond P: Catabolism of lipoproteins and metabolic syndrome. Curr. Opin. Clin. Nutr. Metab. Care 12(4), 366-371 (2009).
88. Wierzbicki AS: Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia. Curr. Opin. Cardiol. 24(4), 372-379 (2009).
89. Kannel WB, Vasan RS: Triglycerides as vascular risk factors: new epidemiologic insights. Curr. Opin. Cardiol. 24(4), 345-350 (2009).
90. La Belle M, Krauss RM: Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. J. Lipid. Res. 31(9), 1577-1588 (1990).
91. Camejo G, Lopez A, Lopez F, Quinones J: Interaction of low density lipoproteins with arterial proteoglycans. The role of charge and sialic acid content. Atherosclerosis 55(1), 93-105 (1985).
92. Chait A, Brazg RL, Tribble DL, Krauss RM: Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am. J. Med. 94(4), 350-356 (1993).
93. Lewis GF, Rader DJ: New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96(12), 1221-1232 (2005).
94. Harangi M, Seres I, Harangi J, Paragh G: Benefits and difficulties in measuring HDL subfractions and human paraoxonase-1 activity during statin treatment. Cardiovasc. Drugs Ther. 23(6), 501-510 (2009).
95. Asztalos BF: High-density lipoprotein metabolism and progression of atherosclerosis: new insights from the HDL Atherosclerosis Treatment Study. Curr. Opin. Cardiol. 19(4), 385-391 (2004).
96. Murphy AJ, Woollard KJ: High density lipoprotein - a potent inhibitor of inflammation. Clin. Exp. Pharmacol. Physiol. DOI: 10.1111/j.1440-1681.2009. 05338.x (2009) (Epub ahead of print).
97. Assmann G, Schulte H, von EA, Huang Y: High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 124(Suppl.), S11-S20 (1996).
98. Austin MA, Hokanson JE, Edwards KL: Hypertriglyceridemia as a cardiovascular risk factor. Am. J. Cardiol. 81(4A), B7-B12 (1998).
99. Kannel WB, Castelli WP, Gordon T: Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann. Intern. Med. 90(1), 85-91 (1979).
100. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D: Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 2(8513), 933-936 (1986).
101. Valentaviciene G, Paipaliene P, Nedzelskiene I, Zilinskas J, Anuseviciene OV: The relationship between blood serum lipids and periodontal condition. Stomatologija 8(3), 96-100 (2006).
102. Machado AC, Quirino MR, Nascimento LF: Relation between chronic periodontal disease and plasmatic levels of triglycerides, total cholesterol and fractions. Braz. Oral Res. 19(4), 284-289 (2005).
103. Sridhar R, Byakod G, Pudakalkatti P, Patil R: A study to evaluate the relationship between periodontitis, cardiovascular disease and serum lipid levels. Int. J. Dent. Hyg. 7(2), 144-150 (2009).
104. Izumi A, Yoshihara A, Hirotomi T, Miyazaki H: The relationship between serum lipids and periodontitis in elderly non-smokers. J. Periodontol. 80(5), 740-748 (2009).
105. Nibali L, D'Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS: Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J. Clin. Periodontol. 34(11), 931-937 (2007).
106. Losche W, Karapetow F, Pohl A, Pohl C, Kocher T: Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J. Clin. Periodontol. 27(8), 537-541 (2000).
107. Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos CT: Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am. J. Epidemiol. 151(3), 273-282 (2000).
108. Lim LP, Tay FB, Sum CF, Thai AC: Relationship between markers of metabolic control and inflammation on severity of periodontal disease in patients with diabetes mellitus. J. Clin. Periodontol. 34(2), 118-123 (2007).
109. Katz J, Chaushu G, Sharabi Y: On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease. J. Clin. Periodontol. 28(9), 865-868 (2001).
110. Morita M, Horiuchi M, Kinoshita Y, Yamamoto T, Watanabe T: Relationship between blood triglyceride levels and periodontal status. Community Dent. Health 21(1), 32-36 (2004).
111. Monteiro AM, Jardini MAN, Alves S et al.: Cardiovascular disease parameters in periodontitis. J. Periodontol. 80(3), 378-388 (2009).
112. Soder B, Airila MS, Soder PO, Kari K, Meurman J: Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood. J. Periodontal. Res. 41(5), 411-417 (2006).
113. Fentoglu O, Oz G, Tasdelen P, Uskun E, Aykac Y, Bozkurt FY: Periodontal status in subjects with hyperlipidemia. J. Periodontol. 80(2), 267-273 (2009).
114. Ramirez-Tortosa MC, Quiles JL, Battino M et al.: Periodontitis is associated with altered plasma fatty acids and cardiovascular risk markers. Nutr. Metab. Cardiovasc. Dis. 20(2), 133-139 (2010).
115. Pussinen PJ, Jauhiainen M, Vilkuna- Rautiainen T et al.: Periodontitis decreases the antiatherogenic potency of high density lipoprotein. J. Lipid Res. 45(1), 139-147 (2004).
116. Buhlin K, Gustafsson A, Pockley AG, Frostegard J, Klinge B: Risk factors for cardiovascular disease in patients with periodontitis. Eur. Heart J. 24(23), 2099-2107 (2003).
117. Nishimura F, Taniguchi A, Yamaguchi- Morimoto M et al.: Periodontal infection and dyslipidemia in Type 2 diabetics: association with increased HMG-CoA reductase expression. Horm. Metab. Res. 38(08), 530-535 (2006).
118. Whitman SC: A practical approach to using mice in atherosclerosis research. Clin. Biochem. Rev. 25(1), 81-93 (2004).
119. Kolovou G, Anagnostopoulou K, Mikhailidis DP, Cokkinos DV: Apolipoprotein E knockout models. Curr. Pharm. Des. 14(4), 338-351 (2008).
120. Lalla E, Lamster IB, Hofmann MA et al.: Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol. 23(8), 1405-1411 (2003).
121. Li L, Messas E, Batista EL Jr, Levine RA, Amar S: Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 105(7), 861-867 (2002).
122. Chi H, Messas E, Levine RA, Graves DT, Amar S: Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications. Circulation 110(12), 1678-1685 (2004).
123. Tuomainen AM, Jauhiainen M, Kovanen PT, Metso J, Paju S, Pussinen PJ: Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice. Microb. Pathog. 44(2), 111-117 (2008).
124. Gitlin JM, Loftin CD: Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice. Cardiovasc. Res. 81(2), 400-407 (2009).
125. Cromwell WC, Otvos JD: Low-density lipoprotein particle number and risk for cardiovascular disease. Curr. Atheroscler. Rep. 6(5), 381-387 (2004).
126. Krauss RM: Dietary and genetic effects on low-density lipoprotein heterogeneity. Annu. Rev. Nutr. 21(1), 283-295 (2001).
127. Jain A, Batista EL, Serhan C, Stahl GL, Van Dyke TE: Role for periodontitis in the progression of lipid deposition in an animal model. Infect. Immun. 71(10), 6012-6018 (2003).
128. Ekuni D, Tomofuji T, Sanbe T et al.: Vitamin C intake attenuates the degree of experimental atherosclerosis induced by periodontitis in the rat by decreasing oxidative stress. Arch. Oral Biol. 54(5), 495-502 (2009).
129. Ekuni D, Tomofuji T, Sanbe T et al.: Periodontitis-induced lipid peroxidation in rat descending aorta is involved in the initiation of atherosclerosis. J. Periodontal. Res. 44(4), 434-442 (2009).
130. Tomofuji T, Kusano H, Azuma T, Ekuni D, Yamamoto T, Watanabe T: Effects of a high-cholesterol diet on cell behavior in rat periodontitis. J. Dent. Res. 84(8), 752-756 (2005).
131. Brodala N, Merricks EP, Bellinger DA et al.: Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler. Thromb. Vasc. Biol. 25(7), 1446-1451 (2005).
132. Ebersole JL, Cappelli D, Mott G, Kesavalu L, Holt SC, Singer RE: Systemic manifestations of periodontitis in the non-human primate. J. Periodontal. Res. 34(7), 358-362 (1999).
133. Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, Salomaa V: Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler. Thromb. Vasc. Biol. 27(6), 1433-1439 (2007).
134. Lund HL, Olsen I, Nafstad P, Schwarze P, Ronningen KS: Antibody levels to single bacteria or in combination evaluated against myocardial infarction. J. Clin. Periodontol. 35(6), 473-478 (2008).
135. Soejima H, Oe Y, Nakayama H et al.: Periodontal status and Prevotella intermedia antibody in acute coronary syndrome. Int. J. Cardiol. 137(3), 304-306 (2009).
136. Yamazaki K, Honda T, Domon H et al.: Relationship of periodontal infection to serum antibody levels to periodontopathic bacteria and inflammatory markers in periodontitis patients with coronary heart disease. Clin. Exp. Immunol. 149(3), 445-452 (2007).
137. Furuichi Y, Shimotsu A, Ito H et al.: Associations of periodontal status with general health conditions and serum antibody titers for Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. J. Periodontol. 74(10), 1491-1497 (2003).
138. Craig RG, Yip JK, So MK, Boylan RJ, Socransky SS, Haffajee AD: Relationship of destructive periodontal disease to the acute-phase response. J. Periodontol. 74(7), 1007-1016 (2003).
139. Vilkuna-Rautiainen T, Pussinen PJ, Roivainen M et al.: Serum antibody response to periodontal pathogens and herpes simplex virus in relation to classic risk factors of cardiovascular disease. Int. J. Epidemiol. 35(6), 1486-1494 (2006).
140. Goteiner D, Craig RG, Ashmen R, Janal MN, Eskin B, Lehrman N: Endotoxin levels are associated with high-density lipoprotein, triglycerides, and troponin in patients with acute coronary syndrome and angina: possible contributions from periodontal sources. J. Periodontol. 79(12), 2331-2339 (2008).
141. Beck JD, Eke P, Heiss G et al.: Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation 112(1), 19-24 (2005).
142. Nakano K, Inaba H, Nomura R et al.: Distribution of Porphyromonas gingivalis fimA genotypes in cardiovascular specimens from Japanese patients. Oral Microbiol. Immunol. 23(2), 170-172 (2008).
143. Kozarov E, Sweier D, Shelburne C, Progulske-Fox A, Lopatin D: Detection of bacterial DNA in atheromatous plaques by quantitative PCR. Microbes Infect. 8(3), 687-693 (2006).
144. Pucar A, Milasin J, Lekovic V et al.: Correlation between atherosclerosis and periodontal putative pathogenic bacterial infections in coronary and internal mammary arteries. J. Periodontol. 78(4), 677-682 (2007).
145. Fiehn NE, Larsen T, Christiansen N, Holmstrup P, Schroeder TV: Identification of periodontal pathogens in atherosclerotic vessels. J. Periodontol. 76(5), 731-736 (2005).
146. Aimetti M, Romano F, Nessi F: Microbiologic analysis of periodontal pockets and carotid atheromatous plaques in advanced chronic periodontitis patients. J. Periodontol. 78(9), 1718-1723 (2007).
147. Elkaim R, Dahan M, Kocgozlu L et al.: Prevalence of periodontal pathogens in subgingival lesions, atherosclerotic plaques and healthy blood vessels: a preliminary study. J. Periodontal. Res. 43(2), 224-231 (2008).
148. Saxlin T, Suominen-Taipale L, Kattainen A, Marniemi J, Knuuttila M, Ylostalo P: Association between serum lipid levels and periodontal infection. J. Clin. Periodontol. 35(12), 1040-1047 (2008).
149. Katz J, Flugelman MY, Goldberg A, Heft M: Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J. Periodontol. 73(5), 494-500 (2002).
150. Champagne C, Yoshinari N, Oetjen JA, Riche EL, Beck JD, Offenbacher S: Gender differences in systemic inflammation and atheroma formation following Porphyromonas gingivalis infection in heterozygous apolipoprotein E-deficient mice. J. Periodontal. Res. 44(5), 569-577 (2009).
151. Rufail ML, Schenkein HA, Koertge TE et al.: Atherogenic lipoprotein parameters in patients with aggressive periodontitis. J. Periodontal. Res. 42(6), 495-502 (2007).
152. Rufail ML, Schenkein HA, Barbour SE, Tew JG, van Antwepen R: Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis. J. Lipid. Res. 46(12), 2752-2760 (2005).
153. Al Darmaki S, Schenkein HA, Tew JG, Barbour SE: Differential expression of platelet-activating factor acetylhydrolase in macrophages and monocyte-derived dendritic cells. J. Immunol. 170(1), 167-173 (2003).
154. Barbour SE, Ishihara Y, Fakher M et al.: Monocyte differentiation in localized juvenile periodontitis is skewed toward the dendritic cell phenotype. Infect. Immun. 70(6), 2780-2786 (2002).
155. Pussinen PJ, Vilkuna-Rautiainen T, Alfthan G et al.: Severe periodontitis enhances macrophage activation via increased serum lipopolysaccharide. Arterioscler. Thromb. Vasc. Biol. 24, 2174-2180 (2004).
156. Sonoki K, Nakashima S, Takata Y et al.: Decreased lipid peroxidation following periodontal therapy in Type 2 diabetic patients. J. Periodontol. 77(11), 1907-1913 (2006).
157. Montebugnoli L, Servidio D, Miaton RA et al.: Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease. J. Clin. Periodontol. 32(2), 188-192 (2005).
158. Lopes-Virella MF: Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. Eur. Heart J. 14(Suppl. K), 118-124 (1993).
159. Lakio L, Lehto M, Tuomainen AM et al.: Pro-atherogenic properties of lipopolysaccharide from the periodontal pathogen Actinobacillus actinomycetemcomitans. J Endotoxin. Res 12(1), 57-64 (2006).
160. Bengtsson T, Karlsson H, Gunnarsson P et al.: The periodontal pathogen Porphyromonas gingivalis cleaves ApoB-100 and increases the expression of apoM in LDL in whole blood leading to cell proliferation. J. Intern. Med. 263(5), 558-571 (2008).
161. Kuramitsu HK: Periodontopathic bacteria and their potential involvement in atherosclerosis. Int. J. Oral-Med. Sci. 1, 1-9 (2002).
162. Miyakawa H, Honma K, Qi M, Kuramitsu HK: Interaction of Porphyromonas gingivalis with low-density lipoproteins: implications for a role for periodontitis in atherosclerosis. J. Periodontal. Res. 39(1), 1-9 (2004).
163. Hashimoto M, Kadowaki T, Tsukuba T, Yamamoto K: Selective proteolysis of apolipoprotein B-100 by Arg-gingipain mediates atherosclerosis progression accelerated by bacterial exposure. J. Biochem. 140(5), 713-723 (2006).
164. Kuramitsu HK, Qi M, Kang IC, Chen W: Role for periodontal bacteria in cardiovascular diseases. Ann. Periodontol. 6(1), 41-47 (2001).
165. Kuramitsu HK, Miyakawa H, Qi M, Kang IC: Cellular responses to oral pathogens. Ann. Periodontol. 7(1), 90-94 (2002).
166. Qi M, Miyakawa H, Kuramitsu HK: Porphyromonas gingivalis induces murine macrophage foam cell formation. Microb. Pathog. 35(6), 259-267 (2003).
167. Schenkein HA, Berry CR, Burmeister JA et al.: Anti-cardiolipin antibodies in sera from patients with periodontitis. J. Dent. Res. 82(11), 919-922 (2003).
168. Turkoglu O, Baris N, Kutukculer N, Senarslan O, Guneri S, Atilla G: Evaluation of serum anti-cardiolipin and oxidized low-density lipoprotein levels in chronic periodontitis patients with essential hypertension. J. Periodontol. 79(2), 332-340 (2008).
169. Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C: Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. J. Clin. Periodontol. 31(1), 25-29 (2004).
170. Schenkein HA, Gunsolley JC, Best AM et al.: Antiphosphorylcholine antibody levels are elevated in humans with periodontal diseases. Infect. Immun. 67(9), 4814-4818 (1999).
171. Schenkein HA, Berry CR, Purkall D, Burmeister JA, Brooks CN, Tew JG: Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins. Infect. Immun. 69(11), 6612-6617 (2001).
172. Paju S, Sinisalo J, Pussinen PJ, Valtonen V, Nieminen MS: Is periodontal infection behind the failure of antibiotics to prevent coronary events? Atherosclerosis 193(1), 193-195 (2007).
173. Madan M, Bishayi B, Hoge M, Messas E, Amar S: Doxycycline affects diet- and bacteria-associated atherosclerosis in an ApoE heterozygote murine model: cytokine profiling implications. Atherosclerosis 190(1), 62-72 (2007).
174. Higashi Y, Goto C, Hidaka T et al.: Oral infection-inflammatory pathway, periodontitis, is a risk factor for endothelial dysfunction in patients with coronary artery disease. Atherosclerosis 206(2), 604-610 (2009).
175. Seinost G, Wimmer G, Skerget M et al.: Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am. Heart J. 149(6), 1050-1054 (2005).
176. Elter JR, Hinderliter AL, Offenbacher S et al.: The effects of periodontal therapy on vascular endothelial function: a pilot trial. Am. Heart J. 151(1), 47-47 (2006).
177. D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS: Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am. Heart J. 151(5), 977-984 (2006).
178. Renvert S, Lindahl C, Roos-Jans Ñker AM, Lessem J: Short-term effects of an anti-inflammatory treatment on clinical parameters and serum levels of C-reactive protein and proinflammatory cytokines in subjects with periodontitis. J. Periodontol. 80(6), 892-900 (2009).
179. Vidal F, Figueredo CM, Cordovil I, Fischer RG: Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J. Periodontol. 80(5), 786-791 (2009).
180. Forner L, Nielsen CH, Bendtzen K, Larsen T, Holmstrup P: Increased plasma levels of IL-6 in bacteremic periodontis patients after scaling. J. Clin. Periodontol. 33(10), 724-729 (2006).
181. Lalla E, Kaplan S, Yang J, Roth GA, Papapanou PN, Greenberg S: Effects of periodontal therapy on serum C-reactive protein, sE-selectin, and tumor necrosis factor-a secretion by peripheral blood-derived macrophages in diabetes. A pilot study. J. Periodontal. Res. 42(3), 274-282 (2007).
182. Iwamoto Y, Nishimura F, Soga Y et al.: Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-a, but not adiponectin levels in patients with chronic periodontitis. J. Periodontol. 74(8), 1231-1236 (2003).
183. Ushida Y, Koshy G, Kawashima Y et al.: Changes in serum interleukin-6, C-reactive protein and thrombomodulin levels under periodontal ultrasonic debridement. J. Clin. Periodontol. 35(11), 969-975 (2008).
184. Tonetti MS, D'Aiuto F, Nibali L et al.: Treatment of periodontitis and endothelial function. N. Engl. J. Med. 356(9), 911-920 (2007).
185. Offenbacher S, Beck JD, Moss K et al.: Results from the Periodontitis and Vascular Events (PAVE) study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J. Periodontol. 80(2), 190-201 (2009).
186. Pischon N, Hägewald S, Kunze M et al.: Influence of periodontal therapy on the regulation of soluble cell adhesion molecule expression in aggressive periodontitis patients. J. Periodontol. 78(4), 683-690 (2007).
187. D'Aiuto F, Parkar M, Tonetti MS: Acute effects of periodontal therapy on bio-markers of vascular health. J. Clin. Periodontol. 34(2), 124-129 (2007).
188. Blum A, Kryuger K, Mashiach Eizenberg M et al.: Periodontal care may improve endothelial function. Eur. J. Intern. Med. 18(4), 295-298 (2007). (Pubitemid 46898777)
189. Piconi S, Trabattoni D, Luraghi C et al.: Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness. FASEB J. 23(4), 1196-1204 (2009).
190. Buhlin K, Hultin M, Norderyd O et al.: Periodontal treatment influences risk markers for atherosclerosis in patients with severe periodontitis. Atherosclerosis 206(2), 518-522 (2009).
191. Tuter G, Kurtis B, Serdar M et al.: Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease. J. Clin. Periodontol. 34(8), 673-681 (2007).
192. Losche W, Marshal GJ, Apatzidou DA, Krause S, Kocher T, Kinane DF: Lipoprotein-associated phospholipase A2 and plasma lipids in patients with destructive periodontal disease. J. Clin. Periodontol. 32(6), 640-644 (2005).
193. Bellosta S, Paoletti R, Corsini A: Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation 109(23 Suppl. 1), III50-III57 (2004).
194. Armitage J: The safety of statins in clinical practice. Lancet 370(9601), 1781-1790 (2007).
195. Edens MA, Kuipers F, Stolk RP: Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers. Obes. Rev. 10(4), 412-419 (2009).
196. Musso G, Gambino R, Cassader M: Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog. Lipid Res. 48(1), 1-26 (2009).
197. Fryirs M, Barter PJ, Rye KA: Cholesterol metabolism and pancreatic b-cell function. Curr. Opin. Lipidol. 20(3), 159-164 (2009).
198. Fernandez ML: The metabolic syndrome. Nutr. Rev. 65(6 Pt 2), S30-S34 (2007).
199. Mihic M, Modi P: Metabolic syndrome - risk factors for atherosclerosis and diabetes. Curr. Diabetes Rev. 4(2), 122-128 (2008).